Matthew Korenberg
About Matthew Korenberg
Matthew Korenberg: President & Chief Operating Officer
Matthew Korenberg currently serves as the President and Chief Operating Officer (COO). In this role, he oversees daily operations, corporate strategy, and organizational policies. His responsibilities include managing key business functions and ensuring operational efficiency across various departments. Korenberg's leadership is instrumental in steering the company's growth and performance in a competitive market.
Matthew Korenberg: Chief Financial Officer Experience (2015-2022)
Matthew Korenberg served as the Chief Financial Officer (CFO) from 2015 to 2022. As CFO, he was responsible for managing the company's financial strategies, overseeing budgeting and forecasting processes, and ensuring financial compliance. His role involved significant contributions to financial planning, analysis, and risk management, helping the company achieve its fiscal objectives.
Founder of NeuroCircuit Therapeutics
Matthew Korenberg founded NeuroCircuit Therapeutics, a company that specializes in developing drugs to treat genetic disorders of the brain. During his tenure as Chief Executive Officer (CEO) and director, he led initiatives to advance therapeutic solutions for neurological genetic disorders. His leadership at NeuroCircuit Therapeutics emphasized innovative research and development in the field of brain health.
Goldman Sachs Healthcare Investment Banking
Matthew Korenberg worked at Goldman Sachs for 14 years as a Managing Director and member of the healthcare investment banking team. His role involved advising biotechnology and pharmaceutical companies on financing strategies, mergers and acquisitions, and market positioning. His extensive experience facilitated numerous successful transactions and helped companies in the healthcare sector secure vital funding.
Board Member at Qualigen Therapeutics, Inc.
Matthew Korenberg serves on the board of directors at Qualigen Therapeutics, Inc., an oncology-focused therapeutics company. He is a member of the audit and compensation committees, where he contributes to strategic decision-making and corporate governance. His involvement aids in steering the company's goals in oncology research and development.
Education in Finance and Accounting from University of Michigan
Matthew Korenberg holds a Bachelor's degree in Business Administration (BBA) with a focus on Finance and Accounting from the University of Michigan. This educational background has equipped him with the essential knowledge and skills for his roles in financial management and corporate leadership. His academic credentials complement his extensive professional experience in finance and investment banking.